A patient-centered look at how migraine symptoms, unpredictable attacks, treatment limits, workplace triggers, and difficulty taking breaks can shape productivity, attendance, and career decisions.
Audience: People living with migraine
Countries: 6
Completion Rate: 62.9%
SGID: 8981120
-Hero findings
– Quick Read — Key Findings
A migraine attack can affect pain, vision, sensitivity to light and sound, nausea, energy, memory, and concentration. At work, that means the same person may be able to function normally on one day and need to stop, rest, leave, or change plans on another.
WHO describes migraine as a recurrent neurological disorder that can be disabling and can reduce workplace productivity, and the survey makes that concrete: most respondents are currently working, yet symptoms can change how they schedule tasks, respond when treatment fails, and decide whether they can keep working through an attack. The story is not simply whether people with migraine can work, but how often the workday has to bend around an illness that arrives quickly and behaves differently from one attack to the next.
Severe head pain is the most selected symptom affecting work at 47.7%, followed by light or sound sensitivity at 33.0%.
Symptoms do not have to be the most severe to become disruptive for someone trying to finish a task, join a meeting, travel home safely, or hold a patient- or customer-facing role: light sensitivity makes screens and fluorescent lighting difficult, brain fog interferes with concentration and recall, and nausea can make staying at a workstation unrealistic. The open responses add texture, patients describe visual aura, difficulty thinking, light sensitivity, vomiting, having to lie down or find a dark room or leave work, and worry about getting home safely while symptoms escalated.
35.2% keep plans flexible, 29.5% avoid scheduling important tasks, and 25.0% cancel plans during attacks.
This planning behavior helps explain why 56.8% select reduced productivity as the greatest work-related impact: productivity loss can happen without a full day of absence, as a person moves more slowly, postpones demanding tasks, steps away from screens, or works around symptoms. WHO similarly notes migraine can cut productivity even when people keep working, and here that appears in both the numbers and the narratives, altered schedules, missed time, delayed starts, and concentration failing long before someone can fully step away.
40.2% identify incomplete symptom relief as the biggest limitation of acute treatment, while treatment side effects and delayed treatment each account for 24.1%.
Incomplete symptom relief
Treatment side effects
Delayed treatment
Limited access or cost
When the first treatment does not work, 31.0% stop work and rest, 29.9% take prescribed rescue treatment, 25.3% wait for symptoms to resolve, and 13.8% contact a healthcare provider, so no single fallback dominates. American Migraine Foundation guidance notes acute treatment is meant to relieve an attack as it happens and works best taken early, which is hard in a work setting if medication is not immediately available, symptoms escalate quickly, or a person cannot leave a task or meeting when the attack begins.
Screen or bright-light exposure is the most selected workplace trigger or worsening factor at 36.8%, closely followed by noise or workplace stress at 34.5%.
Yet the most selected workplace barrier is difficulty taking breaks, also at 36.8%, followed by inflexible schedules at 33.3%, limited manager understanding at 16.1%, and difficulty requesting accommodations at 13.8%. This creates a practical mismatch, the environment can contain the very conditions that worsen symptoms while the workflow makes it hard to step away, and although American Migraine Foundation workplace resources describe accommodations around lighting, sound, seating, remote work, and breaks, the survey suggests break access and schedule flexibility may matter most to this group.
35.6% report missed workdays or shifts, while 31.0% report reduced hours or responsibilities. Another 5.7% say migraine has changed jobs or career plans.
The open responses show how the impact plays out, some patients describe repeated call-outs, reprimands, leaving early, stepping down from demanding roles, or needing a dark space before resuming, while others describe understanding managers or colleagues and a minority report no major impact. Asked what would best support working with migraine, 47.1% choose more effective acute treatments, 32.2% flexible work arrangements, 16.1% better accommodations, and 4.6% faster specialist access, so the strongest preference is treatment-related, with workplace flexibility a substantial second lever.
The survey shows a workday shaped by uncertainty: pain and sensory symptoms interrupt concentration, acute treatment does not always restore function quickly, and common workplace exposures can make an attack harder to manage, yet many respondents keep working and adapt by keeping plans flexible, resting when treatment fails, or changing how much they take on.
The bigger story is that migraine management at work needs two things together, treatment that controls symptoms reliably enough, and a workplace that allows practical flexibility when it does not. More effective acute therapy is the most requested improvement, but flexible schedules, break access, and accommodations remain important because even good treatment cannot guarantee every attack behaves predictably.
You have read the summary
Discover the complete research behind these insights, or become part of future studies with MDForLives.
Direct answers to common questions about symptoms, treatment, productivity, triggers, and workplace support.
Direct answers to the questions healthcare professionals are most likely to ask about these findings.
